AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16330117
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of rofecoxib (n=21)
Trial: 8553632
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy (control group)
Trial: 24879552
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy exercise program for 3 months
Trial: 7485297
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available dinoprostone gel 0.5 mg
Trial: 18593524
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium DR tablet (500 mg), fasting
Trial: 18593524
Drug: VPA DR
RxNorm normalized name: Dr. Numb
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VPA DR soft gelatin capsule (500 mg), fasting
Trial: 17300592
Drug: Vildagliptin 50
RxNorm normalized name: vildagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 50 mg daily
Trial: 17300592
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 mg daily
Trial: 25161155
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg empagliflozin
Trial: 19184556
Drug: BIS-augmentation group
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIS-augmentation group (n = 32)
Trial: 31666832
Drug: Evening primrose
RxNorm normalized name: EVENING PRIMROSE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening primrose 1000 mg orally for two days prior to hysterosalpingography
Trial: 17209786
Drug: Pregnancy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pregnancy without periodontal treatment
Trial: 10869918
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside infusion at a rate of 1 to 2.5 mcg/kg/min to maintain moderate controlled hypotension
Trial: 22985137
Drug: Telephone administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telephone administration
Trial: 29101186
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (target <120 mm Hg) with mean arterial pressure reduction ≥40 mm Hg
Trial: 20102847
Drug: Whole-grain RTE
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain RTE oat cereal (3 g/day oat b‐glucan)
Trial: 19253862
Drug: Ocimum sanctum
RxNorm normalized name: Ocimum Sanctum
DrugBank: Ocimum tenuiflorum top (DB14273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocimum sanctum leaf extract (500 mg/capsule, twice daily, p.o. after meal)
Trial: 20835552
Drug: Sevoflurane +
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane + 0.1 mg/kg vecuronium
Trial: 8589319
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) at a dose of 0.125 IU/kg per week for the first 4 weeks and 0.25 IU/kg per week thereafter
Trial: 16060200
Drug: Adverse drug
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse drug reactions, clinical global impression (CGI), HAMD, mini international psychiatric Interview, Pittsburgh sleep quality index, Side‐effects checklist, Short Form 12, treatment credibility questionnaire, work and social disability scale
Trial: 10861309
Drug: Retinyl palmitate
RxNorm normalized name: Retinyl palmitate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retinyl palmitate (300000 IU daily for 1 year followed by 150000 IU for a 2nd year)
Trial: 6817658
Drug: Inhaled cromoglycate
RxNorm normalized name: cromoglycate
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled cromoglycate
Trial: 27153360
Drug: Fulranumab 10
RxNorm normalized name: Fulranumab
DrugBank: Fulranumab (DB12102)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulranumab 10 mg (10 mgQ4 wk)
Trial: 11012556
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive (30 microg ethinylestradiol and 75 microg gestodene)
Trial: 16472283
Drug: ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ciprofloxacin 500 mg twice daily for 7 days
Trial: 11737926
Drug: 5% albumin
RxNorm normalized name: Flexbumin 5% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% albumin solution (500 ml over 1 h)
Trial: 18376350
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose load
Trial: 26681757
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progestin therapy
Trial: 2162749
Drug: (R)-propafenone hydrochloride
RxNorm normalized name: Propafenone Hydrochloride
DrugBank: (R)-Propafenone (DB19162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R)-propafenone hydrochloride 150 mg
Trial: 7800129
Drug: Multidrug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug chemotherapy (6‐thioguanine, dibromodulcitol, procarbazine, 1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea, 5‐fluorouracil, and hydroxyurea)
Trial: 7800129
Drug: Multidrug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug chemotherapy
Trial: 3144919
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol patch (0.1 mg, n = 10)
Trial: 24800362
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (Diclofenac sodium, Anti Spasmodic (Drotverine HCl), Proton Pump inhibitor (Omeprazole 20 mg) once daily)
Trial: 11603418
Drug: Spironolactone at
RxNorm normalized name: Spironolactone
DrugBank: Spironolactone (DB00421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spironolactone at a mean dose of 25 mg/day
Trial: 26889783
Drug: Virgin Olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virgin Olive Oil enriched with its own phenolic compounds (FVOO)
Trial: 26889783
Drug: Virgin Olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virgin Olive Oil complemented with thyme phenolic compounds (FVOOT)
Trial: 25862517
Drug: Maintenance treatment
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance treatment with capecitabine and bevacizumab
Trial: 16432265
Drug: Ramelteon 64
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 64 mg
Trial: 9015519
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ivermectin (LDIC group)
Trial: 10192639
Drug: Tacrine hydrochloride
RxNorm normalized name: Tacrine Hydrochloride
DrugBank: Tacrine (DB00382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrine hydrochloride (maximum dose administered for 30 weeks)
Trial: 12698087
Drug: Sirolimus (SRL)
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus (SRL) 2 mg/day with early withdrawal of CsA (group II)
Trial: 21336155
Drug: pilocarpine 1%
RxNorm normalized name: PILOCARPINE 1% SOLN,OPH
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pilocarpine 1% 4 times daily
Trial: 11685491
Drug: Low-dose therapy
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose therapy (60 Gy)
Trial: 511533
Drug: Clonazepam (Rivotril)
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonazepam (Rivotril) 2 mg per day
Trial: 1986730
Drug: Thiamine at
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiamine at 3 g/d
Trial: 333252
Drug: Doxepin 75
RxNorm normalized name: doxepin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin 75 mg daily for 14 days
Trial: 7752826
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CoQ), 3.0‐3.4 mg/kg/day for 7 days
Trial: 3512031
Drug: Conventional low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Conventional low-dose heparin
Trial: 24363238
Drug: Frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frovatriptan 2.5 mg alone (Frova)
Trial: 6363970
Drug: Central anticholinergic
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central anticholinergic therapy
Trial: 27181790
Drug: Bremelanotide (BMT)
DrugBank: Bremelanotide (DB11653)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bremelanotide (BMT) 1.25/1.75 mg
Trial: 2997092
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (prednisone for six days)
Trial: 17562035
Drug: Combination (CM)
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (CM)
Trial: 21289226
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D + calcium-fortified yogurt drink (DCY; containing 500 IU vitamin D(3) and 250 mg Ca/250 mL)
Trial: 19337745
Drug: Acetazolamide 125
RxNorm normalized name: acetazolamide 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide 125 mg (ACZ)
Trial: 16325084
Drug: Transfemoral fixation
RxNorm normalized name: phenylephrine hydrochloride Ophthalmic Solution [AK-Dilate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfemoral fixation implant (Transfix; Arthrex) and interference screw (Arthrex) in the tibial tunnel
Trial: 2250075
Drug: Topically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topically applied fluorescein gel
Trial: 30780194
Drug: Standard-dose clarithromycin
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose clarithromycin group (esomeprazole 20 mg bid, amoxicillin 1 g bid, clarithromycin 500 mg bid, bismuth potassium citrate 0.6 g bid) for 14 days
Trial: 8295604
Drug: Dihydroergotamine tartrate
RxNorm normalized name: dihydroergotamine tartrate
DrugBank: Dihydroergotamine (DB00320)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine tartrate (DHE) 2 mg
Trial: 15174232
Drug: Interferon beta
RxNorm normalized name: Interferon beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta 1a (Avonex) treatment, 30 mcg once a week
Trial: 6135029
Drug: Reduction of
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduction of CyA dose
Trial: 17634487
Drug: Short-term androgen-deprivation
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term androgen-deprivation therapy (STAD) plus radiotherapy (RT)
Trial: 26247960
Drug: EPA +
RxNorm normalized name: Eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPA + DHA supplementation (0-4 portions of oily fish/week, equivalent to 3.27 g EPA+DHA per portion)
Trial: 18815665
Drug: Amiodarone (AMD)
DrugBank: Amiodarone (DB01118)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amiodarone (AMD) treatment
Trial: 8786016
Drug: ALA 600
RxNorm normalized name: ALA
DrugBank: alpha-Linolenic acid (DB00132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA 600 mg
Trial: 26690825
Drug: High visceral
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High visceral fat to subcutaneous fat ratio (VFA/SFA)
Trial: 31342566
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of lingonberry extract and 60 mg of amla fruit extract
Trial: 2087535
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone releasing factor (GRF) 1 microgram/kg
Trial: 25778933
Drug: Quarter dose
RxNorm normalized name: Quarter Mate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quarter dose combination (paracetamol 250 mg and ibuprofen 75 mg)
Trial: 16728451
Drug: BT +
RxNorm normalized name: BTS
DrugBank: Pyruvic acid (DB00119)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BT + L-NAME
Trial: 8149518
Drug: Intensive cholesterol-lowering
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive cholesterol-lowering treatment for 90 days
Trial: 10582974
Drug: Serum total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum total cholesterol > or = 7.0 mmol/L
Trial: 31264757
Drug: Efpeglenatide 6
RxNorm normalized name: Efpeglenatide
DrugBank: Efpeglenatide (DB15650)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efpeglenatide 6 mg once every 2 weeks
Trial: 29450452
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy alone
Trial: 8823470
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy plus 13‐cis‐retinoic acid (RA)
Trial: 28859020
Drug: Nonsteroidal anti-inflammatory
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal anti-inflammatory drugs for 2 weeks
Trial: 16875041
Drug: Low-Carbohydrate Diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Carbohydrate Diet (< 30 g/day)
Trial: 10687523
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of flurbiprofen and tramadol
Trial: 15480643
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy at energy level E1=0.15 mJ/mm2
Trial: 22456294
Drug: Vildagliptin 50
RxNorm normalized name: vildagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 50 mg administered 30 min before meals
Trial: 19115653
Drug: Lumbar wedge
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lumbar wedge (group L)
Trial: 17717285
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin therapy
Trial: 22699129
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine 1.5 mg/kg bolus followed by continuous infusion of 1.5 mg/kg/h, stopped 1 hour after skin closure
Trial: 28545041
Drug: Early measles
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early measles vaccine (MV) at 18 weeks of age
Trial: 8163828
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses
Trial: 26239482
Drug: Caffeine and
RxNorm normalized name: caffeine and sodium benzoate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine and albuterol
Trial: 9140151
Drug: 13C-urea breath
RxNorm normalized name: 13C-urea
DrugBank: Urea C-13 (DB09510)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 13C-urea breath test (UBT) with 75 mg 13C-urea and citric acid
Trial: 15088864
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of diazepam
Trial: 15204893
Drug: Life Review
RxNorm normalized name: Life-O-Gen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life Review Therapy (3 one-hour sessions)
Trial: 29392846
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannulae (HFNC) therapy
Trial: 30400924
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) supplement for 6 weeks
Trial: 7740443
Drug: Dermatan sulphate
RxNorm normalized name: Dermatan sulphate
DrugBank: Dermatan sulfate (DB15880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermatan sulphate 200 mg once daily
Trial: 8601548
Drug: Haloperidol 0.2
RxNorm normalized name: haloperidol 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 0.2 mg/kg/day
Trial: 18516012
Drug: Levofloxacin 300
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 300 mg, amoxicillin 1 g, and pantoprazole 20 mg, given twice daily for 7 days (LAP group)
Trial: 12749965
Drug: Intravenous adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous adenosine (50 microg/kg/min over 60min)
Trial: 16642606
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at 'Kaiyin point No. 1', once daily for 7 days.
Trial: 11502788
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (Premarin, 0.625 mg/d)
Trial: 23537965
Drug: Clinical pharmacy
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical pharmacy specialist-, telephone-administered intervention
Trial: 30213173
Drug: Postoperative parecoxib
RxNorm normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Postoperative parecoxib administration (40 mg at wound closure and at 12 and 24 hours after the first dose)
Trial: 8881624
Drug: Thiopentone 4
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 4 mg kg‐1
Trial: 12855302
Drug: Smaller stride
RxNorm normalized name: Stridex
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smaller stride length (L)
Trial: 29676980
Drug: medium viscosity
RxNorm normalized name: LUBRICANT,SIL-OPHTHO MEDIUM VISCOSITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: medium viscosity gel without HP (negative control)
Trial: 29433493
Drug: Integrated Individual
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated Individual Placement and Support (IPS) with pain treatment
Trial: 20075952
Drug: Epoetin-alfa treatment
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin-alfa treatment to a target hemoglobin level of 13.5 g/dl
Trial: 17392660
Drug: Alcohol septal
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol septal ablation (ASA) - 1-3 ml of absolute alcohol introduced into the septal branch to create a controlled septal infarction.
Trial: 29888938
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion for alien control
Trial: 31759909
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of a legume-based food product administered daily for three months (5 days on, 2 days off)
Trial: 30650265
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese herbal medicine ointment
Trial: 19678919
Drug: Study therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Study therapy initiation and volume management
Trial: 8768841
Drug: GHRH administration
RxNorm normalized name: GHRH(1-44)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH administration after transdermal estrogens
Trial: 1847128
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy (HFX) with total doses of 69.6 Gy